Y-Intercept (Hong Kong) Ltd ACAD — ACADIA PHARMACEUTICALS INC

Ownership history in Y-Intercept (Hong Kong) Ltd  ·  14 quarters on record

AI Ownership Summary

Y-Intercept (Hong Kong) Ltd reported ACADIA PHARMACEUTICALS INC (ACAD) in 14 quarterly 13F filings from 2024 Q1 through 2026 Q1. Peak portfolio weight reached 0.2% in 2024 Q1. The latest visible filing shows ACAD at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ACAD ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Y-Intercept (Hong Kong) Ltd's position in ACADIA PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

ACAD was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.2% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

ACAD stock page Y-Intercept (Hong Kong) Ltd fund profile Y-Intercept (Hong Kong) Ltd full holdings
How Y-Intercept (Hong Kong) Ltd held ACAD — position size vs. price
% of Fund (quarterly)    ACAD price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED — — — 25,664 -85,609 -76.9% 0.01% $571K 2026-04-27 $22.30
2025 Q3 ADDED — — — 111,273 +96,746 +666.0% 0.06% $2.4M 2025-10-31 $22.70
2025 Q1 REDUCED 55.9% +29.9% ❌ 14,527 -18,378 -55.9% 0.02% $241K 2025-05-06 $14.54
2024 Q4 REDUCED 34.9% -9.5% ✅ 32,905 -17,639 -34.9% 0.04% $604K 2025-02-04 $18.73
2024 Q3 REDUCED 43.7% +8.5% ❌ 50,544 -39,245 -43.7% 0.05% $777K 2024-11-15 $16.77
2024 Q2 REDUCED 36.5% -5.3% ✅ 89,789 -51,647 -36.5% 0.08% $1.5M 2024-08-14 $15.14
2024 Q1 ADDED — — — 141,436 +72,549 +105.3% 0.20% $2.6M 2024-05-10 $15.25
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding ACAD

As of 2026 Q1 — sorted by position size

Axecap Investments, LLC 2.34% PSP Research LLC 0.31% Yorktown Management & Research Co Inc 3Y 7Y 0.22% PROFUND ADVISORS LLC 3Y 7Y 0.07% Abel Hall, LLC 0.07% Uniting Wealth Partners, LLC 0.05% China Universal Asset Management Co., Ltd. 3Y 0.05% WESBANCO BANK INC 3Y 7Y 0.05% Pictet Asset Management Holding SA 0.05% NJ State Employees Deferred Compensation Plan 3Y 7Y 0.04%

FAQ About Y-Intercept (Hong Kong) Ltd and ACAD

These are the practical questions this page is built to answer before you even open the full history table.

How long has Y-Intercept (Hong Kong) Ltd reported owning ACAD?

Y-Intercept (Hong Kong) Ltd reported ACAD across 7 quarterly 13F filings, from 2024 Q1 through 2026 Q1.

What was the largest reported ACAD position in Y-Intercept (Hong Kong) Ltd's portfolio?

The largest reported portfolio weight for ACAD was 0.20% in 2024 Q1.

What is the latest reported ACAD position on this page?

The most recent filing on this page is 2026 Q1, when Y-Intercept (Hong Kong) Ltd reported 25,664 shares, equal to 0.01% of portfolio, with an estimated market value of $571K.

What does the chart on this ACAD ownership page compare?

The chart compares Y-Intercept (Hong Kong) Ltd's quarterly ACAD portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Y-Intercept (Hong Kong) Ltd time their ACAD position?

Based on 13F filing dates vs. subsequent ACAD price moves, Y-Intercept (Hong Kong) Ltd correctly timed 4 out of 13 reported position changes (31%). The annualised alpha on ACAD relative to SPY over the holding period was -15.5%.

← Back to Y-Intercept (Hong Kong) Ltd Holdings